Cancer Incidence for Ridgewood, Glendale & Middle Village, Queens County, 2015-2019
Source: New York State Cancer Registry
| Site of Cancer | Males and Females | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 847.2 | 416.6 | 404.0-429.6 | 405.4 | 439.4 | 420.0-459.3 | 441.8 | 407.0 | 389.8-424.8 |
| Oral cavity and pharynx | 19.2 | 9.3 | 7.5-11.5 | 13.6 | 14.5 | 11.2-18.5 | 5.6 | 5.0 | 3.3-7.3 |
| Esophagus | 7.6 | 3.6 | 2.6-5.0 | 5.8 | 6.4 | 4.3-9.3 | 1.8 | 1.4 | 0.7-2.9 |
| Stomach | 19.6 | 9.6 | 7.7-11.7 | 10.4 | 11.4 | 8.4-15.0 | 9.2 | 8.3 | 6.0-11.1 |
| Colorectal | 77.6 | 37.9 | 34.2-41.9 | 39.2 | 42.7 | 36.8-49.3 | 38.4 | 34.6 | 29.7-40.0 |
| Colon excluding rectum | 55.2 | 27.0 | 23.8-30.4 | 27.4 | 30.1 | 25.2-35.7 | 27.8 | 24.7 | 20.7-29.3 |
| Rectum & rectosigmoid | 22.4 | 10.9 | 9.0-13.2 | 11.8 | 12.6 | 9.5-16.4 | 10.6 | 9.9 | 7.4-13.0 |
| Liver / intrahepatic bile duct | 21.8 | 10.3 | 8.4-12.4 | 16.6 | 17.0 | 13.5-21.3 | 5.2 | 4.8 | 3.1-7.1 |
| Pancreas | 28.2 | 13.6 | 11.4-16.0 | 11.4 | 12.3 | 9.3-16.1 | 16.8 | 14.3 | 11.3-17.8 |
| Larynx | 6.2 | 3.1 | 2.1-4.4 | 4.8 | 5.1 | 3.2-7.7 | 1.4 | 1.3 | 0.5-2.7 |
| Lung and bronchus | 98.8 | 48.1 | 43.9-52.6 | 48.8 | 54.0 | 47.3-61.4 | 50.0 | 43.7 | 38.4-49.6 |
| Melanoma of the skin | 24.4 | 12.1 | 10.0-14.5 | 11.4 | 13.4 | 10.1-17.5 | 13.0 | 12.0 | 9.2-15.5 |
| Female breast | 121.2 | 113.8 | 104.7-123.5 | ||||||
| Cervix uteri | 8.8 | 8.8 | 6.3-11.9 | ||||||
| Corpus uterus and NOS | 31.0 | 27.6 | 23.4-32.5 | ||||||
| Ovary | 12.2 | 11.7 | 8.9-15.2 | ||||||
| Prostate | 90.0 | 92.0 | 83.5-101.1 | ||||||
| Testis | 3.4 | 3.7 | 2.1-6.0 | ||||||
| Urinary bladder (incl. in situ) | 44.4 | 21.8 | 19.0-24.9 | 35.4 | 40.7 | 34.9-47.3 | 9.0 | 7.8 | 5.6-10.5 |
| Kidney and renal pelvis | 32.6 | 16.4 | 13.9-19.1 | 19.8 | 21.0 | 17.0-25.7 | 12.8 | 12.3 | 9.4-15.9 |
| Brain and other central nervous system | 10.0 | 5.1 | 3.8-6.8 | 4.4 | 4.7 | 2.9-7.2 | 5.6 | 5.5 | 3.6-8.0 |
| Thyroid | 32.6 | 17.6 | 15.0-20.6 | 8.4 | 9.4 | 6.7-12.8 | 24.2 | 25.8 | 21.3-30.9 |
| Hodgkin lymphoma | 4.2 | 2.4 | 1.4-3.7 | 2.8 | 3.1 | 1.7-5.3 | 1.4 | 1.6 | 0.6-3.4 |
| Non-Hodgkin lymphomas | 39.0 | 19.6 | 16.9-22.6 | 21.2 | 23.2 | 18.9-28.1 | 17.8 | 16.4 | 13.1-20.3 |
| Myeloma | 11.0 | 5.3 | 4.0-7.0 | 5.4 | 6.2 | 4.1-9.1 | 5.6 | 4.7 | 3.1-7.0 |
| Leukemias | 27.6 | 14.0 | 11.7-16.6 | 15.8 | 17.3 | 13.6-21.7 | 11.8 | 11.2 | 8.5-14.6 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.
